Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

(Family Features) Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One ...

The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.